Knight Therapeutics Inc. (GUD:CA) Q2 2026 Earnings Call Transcript

· seekingalpha.com

Knight Therapeutics Inc. (GUD:CA) Q2 2026 Earnings Call August 6, 2026 8:30 AM EDTCompany ParticipantsSamira Sakhia - President, CEO & DirectorArvind...

Presentation

Operator

Good morning, ladies and gentlemen. My name is Matthew, and I will be your operator today. Welcome to Knight Therapeutics Second Quarter...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI